Hantz Financial Services’s Pacific Biosciences PACB Stock Holding History

Hantz Financial Services’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	4	–	–	﹤0.01%	2599
2026 Q1	$0	Hold	4	–	–	﹤0.01%	2571
2025 Q4	$0	Hold	4	–	–	﹤0.01%	2504
2025 Q3	$0	Hold	4	–	–	﹤0.01%	2420
2025 Q2	$0	Hold	4	–	–	﹤0.01%	2270
2025 Q1	$0	Hold	4	–	–	﹤0.01%	1902
2024 Q4	$0	Hold	4	–	–	﹤0.01%	1184
2024 Q3	$0	Hold	4	–	–	﹤0.01%	1157
2024 Q2	$0	Hold	4	–	–	﹤0.01%	1213
2024 Q1	$0	Hold	4	–	–	﹤0.01%	1275
2023 Q4	$0	Hold	4	–	–	﹤0.01%	1204
2023 Q3	$0	Hold	4	–	–	﹤0.01%	1173
2023 Q2	$0	Hold	4	–	–	﹤0.01%	1154
2023 Q1	$0	Hold	4	–	–	﹤0.01%	1180
2022 Q4	$0	Hold	4	–	–	﹤0.01%	1140
2022 Q3	$0	Hold	4	–	–	﹤0.01%	1128
2022 Q2	$0	Hold	4	–	–	﹤0.01%	1099
2022 Q1	$0	Hold	4	–	–	﹤0.01%	1105
2021 Q4	$0	Buy	+4	New	+$97	﹤0.01%	896

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Hantz Financial Services's PACB Position: Q2 2026 in Review

Hantz Financial Services held its Pacific Biosciences (PACB) position steady in Q2 2026 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Hantz Financial Services first reported a position in PACB in Q4 2021 and has held it in 19 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Hantz Financial Services held 4 shares of Pacific Biosciences worth $0 as of Q2 2026.
Hantz Financial Services left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2599 holding.
Hantz Financial Services first reported a position in Pacific Biosciences in Q4 2021 and has held it in 19 quarters since.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.